Acetyltransferase machinery conserved in p300/CBP-family proteins

被引:38
|
作者
Yuan, LWC
Giordano, A [1 ]
机构
[1] Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
[2] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA
基金
美国国家卫生研究院;
关键词
p300; CBP; PCAT; histone/protein acetyltransferase; protein domains; protein structure;
D O I
10.1038/sj.onc.1205283
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CREB-binding protein (CBP) and p300 are highly, conserved and functionally related transcription coactivators and histone/protein acetyltransferases. They are, tumor suppressors, participate in a wide variety of physiological events, and serve as integrators among different signal transduction pathways. In this study, 11 distinct proteins that have a high degree of homology with the amino acid sequence of p300 have been identified in current protein databases. All of these, 11 proteins belong to either animal or plant multicellular organisms (higher eucaryotes). Conservation of p300/ CBP domains among these proteins was examined further by sequence alignment and pattern search. The domains of p300/CBP that are required for the HAT function, including PHD, putative CoA-binding, and ZZ domains, are conserved in all of these 11 proteins. This observation is consistent with the previous functional assays and indicates that they are a family of acetyltransferases, i.e. p300/CBP acetyltransferases (PCAT). TAZ domains (TAZ1 and/or TAZ2) of PCAT proteins may allow them to participate in transcription regulation by either directly recruiting transcription factors, acetylating them subsequently, or directing targeted acetylation of nucleosomal histones.
引用
收藏
页码:2253 / 2260
页数:8
相关论文
共 50 条
  • [21] E2A proteins enhance the histone acetyltransferase activity of the transcriptional co-activators CBP and p300
    Hyndman, Brandy D.
    Thompson, Patrick
    Bayly, Richard
    Cote, Graham P.
    LeBrun, David P.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2012, 1819 (05): : 446 - 453
  • [22] Live-Cell Studies of p300/CBP Histone Acetyltransferase Activity and Inhibition
    Dancy, Beverley M.
    Crump, Nicholas T.
    Peterson, Daniel J.
    Mukherjee, Chandrani
    Bowers, Erin M.
    Ahn, Young-Hoon
    Yoshida, Minoru
    Zhang, Jin
    Mahadevan, Louis C.
    Meyers, David J.
    Boeke, Jef D.
    Cole, Philip A.
    CHEMBIOCHEM, 2012, 13 (14) : 2113 - 2121
  • [23] Wnt/β-catenin-dependent acetylation of Pygo2 by CBP/p300 histone acetyltransferase family members
    Andrews, Phillip G. P.
    Kao, Kenneth R.
    BIOCHEMICAL JOURNAL, 2016, 473 : 4193 - 4203
  • [24] p300/CBP与肺癌
    王恩旺
    杨小龙
    中国肺癌杂志, 2009, 12 (08) : 926 - 930
  • [25] The p300/CBP family: Integrating signals with transcription factors and chromatin
    Shikama, N
    Lyon, J
    LaThangue, NB
    TRENDS IN CELL BIOLOGY, 1997, 7 (06) : 230 - 236
  • [26] Targeting CBP/p300 and its downstream transcriptional machinery in advanced prostate cancer
    Sardar, Sumaira
    Ravindranath, Lakshmi
    McNair, Christopher
    Chand, Saswati
    Yuan, Wei
    Bogdan, Denisa
    Welti, Jon
    Sharp, Adam
    Schiewer, Matthew
    Butler, Lisa
    de Bono, Johann
    Frese, Kris
    Brooks, Nigel
    Pegg, Neil
    Knudsen, Karen
    Shafi, Ayesha
    CANCER RESEARCH, 2023, 83 (07)
  • [27] The p48 subunit of the damaged-DNA binding protein DDB associates with the CBP/p300 family of histone acetyltransferase
    Datta, A
    Bagchi, S
    Nag, A
    Shiyanov, P
    Adami, GR
    Yoon, T
    Raychaudhuri, P
    MUTATION RESEARCH-DNA REPAIR, 2001, 486 (02): : 89 - 97
  • [28] MOF as an evolutionarily conserved histone crotonyltransferase and transcriptional activation by histone acetyltransferase-deficient and crotonyltransferase-competent CBP/p300
    Xiaoguang Liu
    Wei Wei
    Yuting Liu
    Xueli Yang
    Jian Wu
    Yang Zhang
    Qiao Zhang
    Tieliu Shi
    James X Du
    Yingming Zhao
    Ming Lei
    Jin-Qiu Zhou
    Jiwen Li
    Jiemin Wong
    Cell Discovery, 3
  • [29] Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
    Chen, Qingjuan
    Yang, Binhui
    Liu, Xiaochen
    Zhang, Xu D.
    Zhang, Lirong
    Liu, Tao
    THERANOSTICS, 2022, 12 (11): : 4935 - 4948
  • [30] MOF as an evolutionarily conserved histone crotonyltransferase and transcriptional activation by histone acetyltransferase-deficient and crotonyltransferase-competent CBP/p300
    Liu, Xiaoguang
    Wei, Wei
    Liu, Yuting
    Yang, Xueli
    Wu, Jian
    Zhang, Yang
    Zhang, Qiao
    Shi, Tieliu
    Du, James X.
    Zhao, Yingming
    Lei, Ming
    Zhou, Jin-Qiu
    Li, Jiwen
    Wong, Jiemin
    CELL DISCOVERY, 2017, 3